189 related articles for article (PubMed ID: 31034485)
1. Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US.
Peasah SK; Meltzer MI; Vu M; Moulia DL; Bridges CB
PLoS One; 2019; 14(4):e0213499. PubMed ID: 31034485
[TBL] [Abstract][Full Text] [Related]
2. Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.
Brydak L; Roiz J; Faivre P; Reygrobellet C
Clin Drug Investig; 2012 Feb; 32(2):73-85. PubMed ID: 22201294
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of influenza vaccination in patients with acute coronary syndrome in Korea.
Suh J; Kim B; Yang Y; Suh DC; Kim E
Vaccine; 2017 May; 35(21):2811-2817. PubMed ID: 28427844
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States.
Clements KM; Meier G; McGarry LJ; Pruttivarasin N; Misurski DA
Hum Vaccin Immunother; 2014; 10(5):1171-80. PubMed ID: 24609063
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.
Yang MC; Tan EC; Su JJ
Hum Vaccin Immunother; 2017 Jan; 13(1):81-89. PubMed ID: 27624648
[TBL] [Abstract][Full Text] [Related]
6. Net Costs Due to Seasonal Influenza Vaccination--United States, 2005-2009.
Carias C; Reed C; Kim IK; Foppa IM; Biggerstaff M; Meltzer MI; Finelli L; Swerdlow DL
PLoS One; 2015; 10(7):e0132922. PubMed ID: 26230271
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial.
Yoo BK; Humiston SG; Szilagyi PG; Schaffer SJ; Long C; Kolasa M
BMC Health Serv Res; 2015 Nov; 15():511. PubMed ID: 26573461
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of seasonal inactivated influenza vaccination among pregnant women.
Xu J; Zhou F; Reed C; Chaves SS; Messonnier M; Kim IK
Vaccine; 2016 Jun; 34(27):3149-3155. PubMed ID: 27161997
[TBL] [Abstract][Full Text] [Related]
9. From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain.
Crépey P; Redondo E; Díez-Domingo J; Ortiz de Lejarazu R; Martinón-Torres F; Gil de Miguel Á; López-Belmonte JL; Alvarez FP; Bricout H; Solozabal M
PLoS One; 2020; 15(5):e0233526. PubMed ID: 32437476
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States.
Clements KM; Chancellor J; Nichol K; DeLong K; Thompson D
Value Health; 2011; 14(6):800-11. PubMed ID: 21914499
[TBL] [Abstract][Full Text] [Related]
11. Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives.
de Fougerolles TR; Baïssas T; Perquier G; Vitoux O; Crépey P; Bartelt-Hofer J; Bricout H; Petitjean A
BMC Public Health; 2024 May; 24(1):1222. PubMed ID: 38702667
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of influenza vaccination. Assessment for The Netherlands.
Postma MJ; Bos JM; van Gennep M; Jager JC; Baltussen R; Sprenger MJ
Pharmacoeconomics; 1999; 16 Suppl 1():33-40. PubMed ID: 10623374
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness Analysis of a Television Campaign to Promote Seasonal Influenza Vaccination Among the Elderly.
Kim M; Yoo BK
Value Health; 2015 Jul; 18(5):622-30. PubMed ID: 26297090
[TBL] [Abstract][Full Text] [Related]
14. Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness.
Prosser LA; O'Brien MA; Molinari NA; Hohman KH; Nichol KL; Messonnier ML; Lieu TA
Pharmacoeconomics; 2008; 26(2):163-78. PubMed ID: 18198935
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States.
de Boer PT; Crépey P; Pitman RJ; Macabeo B; Chit A; Postma MJ
Value Health; 2016 Dec; 19(8):964-975. PubMed ID: 27987647
[TBL] [Abstract][Full Text] [Related]
16. Influenza in the school-aged population in Mexico: burden of disease and cost-effectiveness of vaccination in children.
Falcón-Lezama JA; Saucedo-Martínez R; Betancourt-Cravioto M; Alfaro-Cortes MM; Bahena-González RI; Tapia-Conyer R
BMC Infect Dis; 2020 Mar; 20(1):240. PubMed ID: 32197591
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the U.K.
Meier G; Gregg M; Poulsen Nautrup B
J Med Econ; 2015; 18(9):746-61. PubMed ID: 25903831
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
[TBL] [Abstract][Full Text] [Related]
19. The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain.
Aballéa S; De Juanes JR; Barbieri M; Martin M; Chancellor J; Oyagüez I; Verwee B; Largeron N
Vaccine; 2007 Sep; 25(39-40):6900-10. PubMed ID: 17764790
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities.
You JH; Wong WC; Ip M; Lee NL; Ho SC
J Epidemiol Community Health; 2009 Nov; 63(11):906-11. PubMed ID: 19608558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
